Actively Recruiting
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
Led by University Hospital, Strasbourg, France · Updated on 2025-04-04
100
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due to their increased resistance to many commonly used antibiotics. The aim of this thesis is to study the management of such infections by general practitioners in Bas-Rhin and to suggest possible avenues for improvement.
CONDITIONS
Official Title
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older
- Diagnosed with an Enterobacteriaceae urinary tract infection treated in primary care between June 1, 2024 and December 31, 2024
- Willing to allow reuse of their treatment data for this research
- Primary care physician agrees to participate in the study
You will not qualify if you...
- Patient or their primary care physician refuses to participate in the study
- Patient is under legal protection
- Patient is under guardianship or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg
Strasbourg, France
Actively Recruiting
Research Team
Y
Yves HANSMANN, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here